| Cash flow (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Net income | 2.86B | 2.32B | 1.80B | 1.32B | 1.70B | 1.06B |
| Depreciation and amortization | 600.00M | 439.00M | 382.00M | 326.00M | 280.00M | 221.00M |
| Stock-based compensation | 788.20M | 676.80M | 592.80M | 513.20M | 449.20M | 395.40M |
| Cash from operations | 3.03B | 2.42B | 1.81B | 1.49B | 2.09B | 1.48B |
| Capital expenditure | -539.80M | -1.11B | -1.06B | -532.40M | -339.50M | -341.50M |
| Free cash flow | 2.49B | 1.30B | 749.60M | 958.40M | 1.75B | 1.14B |
| Acquisitions | -13.90M | -1.00M | -8.90M | -12.80M | -22.70M | -37.70M |
| Cash from investing | 665.80M | -3.27B | -360.10M | 1.37B | -2.46B | -940.60M |
| Share buybacks | -2.30B | 0 | -416.30M | -2.61B | 0 | -134.30M |
| Cash from financing | -2.36B | 150.90M | -287.60M | -2.57B | 43.00M | -85.70M |
| Net change in cash | 1.34B | -707.70M | 1.17B | 294.70M | -332.50M | 455.90M |
From Intuitive Surgical's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.